Activity Provided By:

ACHL

The Emerging Role of the Gut Microbiome in Reducing Recurrence of C. difficile Infection

Overview / Abstract:	In this activity, internal medicine and gastroenterology faculty discuss community- and healthcare-associated C. difficile infection, the increasing incidence of recurrent infection, therapy selection, and when to refer to a specialist. The video-based format, with supporting slides and multidisciplinary panel discussions, provides a comprehensive perspective on the challenges faced by clinicians in the recognition and treatment of initial and recurrent C. difficile infection. Internal medicine physicians play a critical role in early identification of CDI symptoms, in order to provide appropriate treatment, and refer to a gastroenterologist. When patients describe having gastrointestinal issues, clinicians need to be aware of updated and changing guidelines and treatment options for C. difficile infection. There needs to be better awareness of the role of the gut microbiota, how to approach initial treatment with antibiotics, and available and emerging approaches to gut microbiota restoration.
Expiration	Jun 23, 2021
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online, Webinar / Webcast / Video
Credits / Hours	1.25 AMA PRA Category 1 Credit(s)
Accreditation	ACCME
Presenters / Authors / Faculty	Paul Feuerstadt MD, FACG, AGAF Assistant Clinical Professor of Medicine Yale University School of Medicine Gastroenterology Center of Connecticut Sahil Khanna, MBBS, MS Associate Professor of Medicine Gastroenterology and Hepatology Mayo Clinic Jason Worcester, MD Assistant Professor of Medicine Boston Medical Center Boston University School of Medicine
Sponsors / Supporters / Grant Providers	This activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.
Keywords / Search Terms	ACHL CME, CE, CME/CE, Continuing Medical Education, Online Learning, Webcast, C. difficile, CDI, Dr. Feuerstadt, Dr. Khanna, Dr. Worcester, Paul Feuerstadt, Sahil Khanna, Jason Worcester, COVID-19, COVID, transmission, recurrent, recurrence, infection, infectious disease, gastrointestinal, internal medicine, physician, fecal microbiota transplantation, FMT, stool, donor, IDSA/SHEA, FDA, efficacy, safety, screening Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map